Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

AXIOMATIC-TKR: Milvexian Promising for VTE Prevention

News Conference News

AXIOMATIC-TKR: Milvexian Promising for VTE Prevention

November 15, 2021

News Conference News AHA 2021

AVATAR Supports Early SAVR in Asymptomatic Severe AS Patients

November 13, 2021

Myocarditis After COVID-19 Vaccine: Data ‘Reassure’ More and More

News Conference News TCT 2021

Myocarditis After COVID-19 Vaccine: Data ‘Reassure’ More and More

November 04, 2021

2021 ESC/EACTS Valve Guidelines Unveil TAVI/SAVR Age Cutoffs and Earlier Care

News Conference News ESC 2021

2021 ESC/EACTS Valve Guidelines Unveil TAVI/SAVR Age Cutoffs and Earlier Care

August 31, 2021

ACST-2: Carotid Stenting, Surgery Provide Similar Outcomes in Asymptomatic Patients

News Conference News ESC 2021

ACST-2: Carotid Stenting, Surgery Provide Similar Outcomes in Asymptomatic Patients

August 29, 2021

STROKE-VT: DOACs Cut Cerebrovascular Events After LV Arrhythmia Ablation

News Conference News HRS 2021

STROKE-VT: DOACs Cut Cerebrovascular Events After LV Arrhythmia Ablation

July 29, 2021

COVID-19’s Effects on Cardiac Imaging Protocols, Perspectives Still Unfolding

News Conference News SCCT 2021

COVID-19’s Effects on Cardiac Imaging Protocols, Perspectives Still Unfolding

Yael L. Maxwell

July 23, 2021

‘Enormous’ QoL Improvements With Mavacamten in HCM

News Conference News ACC 2021

‘Enormous’ QoL Improvements With Mavacamten in HCM

May 15, 2021

No Clear Explanation for Benefits of Early Rhythm Control in EAST-AFNET4

News Conference News EHRA 2021

No Clear Explanation for Benefits of Early Rhythm Control in EAST-AFNET4

April 27, 2021

Adjustable Stent Retriever Performs Well in IDE Trial

News Conference News ISC 2021

Adjustable Stent Retriever Performs Well in IDE Trial

March 24, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.